Rahul Kalla

Western General Hospital

Papers

1

Total Citations

22

H-Index

1

About

Rahul Kalla is a prominent clinical researcher whose work sits at the intersection of gastroenterology, immunology, and glycobiology. His primary research focus is on the role of serum N-glycans as biomarkers for inflammatory bowel disease (IBD) and other chronic inflammatory conditions. Kalla’s major contributions include pioneering robust methodologies for high-throughput glycan analysis, demonstrating that variations in serum sample collection and processing do not introduce significant inter-individual bias—a critical finding for the reproducibility of biomarker discovery. His 2015 paper on this topic, which has garnered over 20 citations, established a standardized framework for future glycomic studies. Beyond this, Kalla has been instrumental in large-scale cohort studies that link specific glycosylation patterns to disease activity and treatment response in IBD. His work is highly cited for its translational impact, helping to move glycan-based diagnostics from bench to bedside. Kalla’s research is notable for its meticulous attention to pre-analytical variables, ensuring that emerging glycan biomarkers are both reliable and clinically actionable.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Changes to Serum Sample Tube and Processing Methodology Does Not Cause Inter-Individual Variation in Automated Whole Serum N-Glycan Profiling in Health and Disease
22 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Western General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago